Verve Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	-9 - -5
Period Ending	Aug '25 Aug 1, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	-9 - -5
Market Capitalization	1,226	1,565	3,568	3,830	14,699	28,986	Upgrade
Market Cap Growth	-7.87%	-56.14%	-6.84%	-73.95%	-49.29%	378.33%	Upgrade
Enterprise Value	1,582	1,910	4,120	4,536	15,162	28,811	Upgrade
Last Close Price	6.94	9.09	21.55	23.65	91.82	199.96	Upgrade
PS Ratio	0.47	0.61	1.37	1.59	7.23	26.50	Upgrade
PB Ratio	0.86	1.05	1.53	1.66	0.92	1.83	Upgrade
P/FCF Ratio	4.20	5.53	10.54	22.16	79.26	-	Upgrade
P/OCF Ratio	-	5.33	10.19	20.23	75.77	-	Upgrade
EV/Sales Ratio	-	0.74	1.58	1.89	7.46	26.34	Upgrade
EV/EBITDA Ratio	-	60.21	94.47	-	-	-	Upgrade
EV/FCF Ratio	5.42	6.75	12.17	26.25	81.76	-	Upgrade
Debt / Equity Ratio	-	1.06	0.69	0.69	0.08	0.09	Upgrade
Debt / EBITDA Ratio	-	35.23	26.96	142.99	-	-	Upgrade
Debt / FCF Ratio	-	5.60	4.70	9.18	7.02	-	Upgrade
Asset Turnover	-	0.65	0.60	0.22	0.12	0.11	Upgrade
Inventory Turnover	-	22.21	17.70	11.50	10.04	-	Upgrade
Quick Ratio	-	1.62	3.22	2.89	3.28	2.87	Upgrade
Current Ratio	-	1.77	3.54	3.29	3.70	3.19	Upgrade
Return on Equity (ROE)	-	-52.46%	-9.51%	-148.85%	-2.69%	-5.74%	Upgrade
Return on Assets (ROA)	-	-3.30%	-3.01%	-1.23%	-0.84%	-2.70%	Upgrade
Return on Capital (ROIC)	-	-3.73%	-3.37%	-1.28%	-0.86%	-2.77%	Upgrade
Earnings Yield	-	-63.98%	-6.18%	-356.69%	-2.92%	-1.67%	Upgrade
FCF Yield	23.79%	18.08%	9.49%	4.51%	1.26%	-0.20%	Upgrade
Buyback Yield / Dilution	-3.77%	-3.64%	-1.93%	-2.88%	-73.40%	-25.98%	Upgrade

Updated Jul 29, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q